Essential Perspectives: Focus on Hemophilia/ASH 2013 Annual Meeting

This activity presents key findings from 4 poster presentations: including 2 on emerging long-half-life clotting factor replacements, as well as data on the long-term safety of an existing clotting factor replacement, and a novel immunosuppressive regimen for acquired hemophilia A, presented at the American Society of Hematology Annual Meeting held in New Orleans, Louisiana from December 7-10, 2013

Target Audience

This activity was developed for hematologists and other clinicians who treat patients with hemophilia.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
07/31/2014
Course expires: 
07/30/2015
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.